Elevated Preoperative Neutrophil/lymphocyte Ratio is Associated with Poor Prognosis in Soft-tissue Sarcoma Patients

Overview

Journal Br J Cancer

Specialty Oncology

Date 2013 Apr 6

PMID 23558897

Citations 75

Authors

J Szkandera

G Absenger

B Liegl-Atzwanger

M Pichler

M Stotz

H Samonigg

M Glehr

M Zacherl

T Stojakovic

A Gerger

A Leithner

Affiliations

Soon will be listed here.

Abstract

Background: Recent data indicate that tumour microenvironment, which is influenced by inflammatory cells, has a crucial role in cancer progression and clinical outcome of patients. In the present study, we investigated the prognostic relevance of preoperative neutrophil/lymphocyte (N/L) ratio on time to tumour recurrence (TTR) and overall survival (OS) in soft-tissue sarcoma (STS) patients who underwent curative surgical resection.

Methods: In all, 260 STS patients were included in this retrospective study. Kaplan-Meier curves and multivariate Cox proportional models were calculated for TTR and OS.

Results: In univariate analysis, elevated N/L ratio was significantly associated with decreased TTR (hazard ratio (HR), 2.32; 95% confidence interval (CI), 1.30-4.14; P=0.005) and remained significant in the multivariate analysis (HR, 1.98; 95%CI, 1.05-3.71; P=0.035). Patients with elevated N/L ratio showed a median TTR of 77.9 months. In contrast, patients with low N/L ratio had a median TTR of 99.1 months. Regarding OS, elevated N/L ratio was also significantly associated with decreased survival in univariate analysis (HR, 2.90; 95%CI, 1.82-4.61; P=0.001) and remained significant in multivariate analysis (HR, 1.88; 95%CI, 1.14-3.12; P=0.014).

Conclusion: In conclusion, our findings suggest that an elevated preoperative N/L ratio predicts poor clinical outcome in STS patients and may serve as a cost-effective and broadly available independent prognostic biomarker.

Citing Articles

Neutrophil-to-lymphocyte, platelet-to-lymphocyte ratios and systemic immune-inflammation index in patients with post-traumatic stress disorder.

Yontar G, Mutlu E BMC Psychiatry. 2024; 24(1):966.

PMID: 39741243 PMC: 11686920. DOI: 10.1186/s12888-024-06439-y.

Peripheral immune profiling of soft tissue sarcoma: perspectives for disease monitoring.

Almeida J, Sousa L, Couceiro P, Andrade T, Alves V, Martinho A Front Immunol. 2024; 15:1391840.

PMID: 39502689 PMC: 11536262. DOI: 10.3389/fimmu.2024.1391840.

A study of pre- and post-treatment hematologic markers of immune response in patients undergoing radiotherapy for soft tissue sarcoma.

Ku E, Harada G, Lee G, Munjal A, Peterson N, Park J Front Oncol. 2024; 14:1392705.

PMID: 39421451 PMC: 11484061. DOI: 10.3389/fonc.2024.1392705.

Multi-omics differences in the bone marrow between essential thrombocythemia and prefibrotic primary myelofibrosis.

Zhang A, Sun T, Yu D, Fu R, Liu X, Xue F Clin Exp Med. 2024; 24(1):154.

PMID: 38972952 PMC: 11228008. DOI: 10.1007/s10238-024-01350-y.

Development and Validation of a Prognostic Nomogram for HR+ HER- Breast Cancer.

Zhou J, Pan C, Ye Y, Li Z, Fu W, Jiang B Cancer Manag Res. 2024; 16:491-505.

PMID: 38800665 PMC: 11127650. DOI: 10.2147/CMAR.S459714.

References

Clark E, Connor S, Taylor M, Madhavan K, Garden O, Parks R . Preoperative lymphocyte count as a prognostic factor in resected pancreatic ductal adenocarcinoma. HPB (Oxford). 2008; 9(6):456-60. PMC: 2215360. DOI: 10.1080/13651820701774891. View

Borden E, Baker L, Bell R, Bramwell V, Demetri G, Eisenberg B . Soft tissue sarcomas of adults: state of the translational science. Clin Cancer Res. 2003; 9(6):1941-56. View

Lee Y, Choi C, Kim H, Kim T, Lee J, Lee J . Pretreatment neutrophil:lymphocyte ratio as a prognostic factor in cervical carcinoma. Anticancer Res. 2012; 32(4):1555-61. View

Schaider H, Oka M, Bogenrieder T, Nesbit M, Satyamoorthy K, Berking C . Differential response of primary and metastatic melanomas to neutrophils attracted by IL-8. Int J Cancer. 2002; 103(3):335-43. DOI: 10.1002/ijc.10775. View

Petrie H, Klassen L, Kay H . Inhibition of human cytotoxic T lymphocyte activity in vitro by autologous peripheral blood granulocytes. J Immunol. 1985; 134(1):230-4. View

Kattan M, Leung D, Brennan M . Postoperative nomogram for 12-year sarcoma-specific death. J Clin Oncol. 2002; 20(3):791-6. DOI: 10.1200/JCO.2002.20.3.791. View

Sarraf K, Belcher E, Raevsky E, Nicholson A, Goldstraw P, Lim E . Neutrophil/lymphocyte ratio and its association with survival after complete resection in non-small cell lung cancer. J Thorac Cardiovasc Surg. 2009; 137(2):425-8. DOI: 10.1016/j.jtcvs.2008.05.046. View

Mallappa S, Sinha A, Gupta S, Chadwick S . Preoperative neutrophil to lymphocyte ratio >5 is a prognostic factor for recurrent colorectal cancer. Colorectal Dis. 2012; 15(3):323-8. DOI: 10.1111/codi.12008. View

Idowu O, Ding Q, Taktak A, Chandrasekar C, Yin Q . Clinical implication of pretreatment neutrophil to lymphocyte ratio in soft tissue sarcoma. Biomarkers. 2012; 17(6):539-44. DOI: 10.3109/1354750X.2012.699554. View

10.

Coussens L, Werb Z . Inflammation and cancer. Nature. 2002; 420(6917):860-7. PMC: 2803035. DOI: 10.1038/nature01322. View

11.

Coindre J . Grading of soft tissue sarcomas: review and update. Arch Pathol Lab Med. 2006; 130(10):1448-53. DOI: 10.5858/2006-130-1448-GOSTSR. View

12.

Teramukai S, Kitano T, Kishida Y, Kawahara M, Kubota K, Komuta K . Pretreatment neutrophil count as an independent prognostic factor in advanced non-small-cell lung cancer: an analysis of Japan Multinational Trial Organisation LC00-03. Eur J Cancer. 2009; 45(11):1950-8. DOI: 10.1016/j.ejca.2009.01.023. View

13.

Gousias K, Becker A, Simon M, Niehusmann P . Nuclear karyopherin a2: a novel biomarker for infiltrative astrocytomas. J Neurooncol. 2012; 109(3):545-53. DOI: 10.1007/s11060-012-0924-2. View

14.

Jilma B, Blann A, Pernerstorfer T, Stohlawetz P, Eichler H, Vondrovec B . Regulation of adhesion molecules during human endotoxemia. No acute effects of aspirin. Am J Respir Crit Care Med. 1999; 159(3):857-63. DOI: 10.1164/ajrccm.159.3.9805087. View

15.

ENNEKING W, Spanier S, Goodman M . A system for the surgical staging of musculoskeletal sarcoma. Clin Orthop Relat Res. 1980; (153):106-20. View

16.

Clark R . Immunosuppression by activated human neutrophils. Dependence on the myeloperoxidase system. J Immunol. 1987; 139(7):2406-13. View

17.

Siegel R, Naishadham D, Jemal A . Cancer statistics, 2012. CA Cancer J Clin. 2012; 62(1):10-29. DOI: 10.3322/caac.20138. View

18.

Cho H, Hur H, Kim S, Kim S, Kim J, Kim Y . Pre-treatment neutrophil to lymphocyte ratio is elevated in epithelial ovarian cancer and predicts survival after treatment. Cancer Immunol Immunother. 2008; 58(1):15-23. PMC: 11029845. DOI: 10.1007/s00262-008-0516-3. View

19.

Chen Z, Gerhold-Ay A, Gebhard S, Boehm D, Solbach C, Lebrecht A . Immunoglobulin kappa C predicts overall survival in node-negative breast cancer. PLoS One. 2012; 7(9):e44741. PMC: 3461001. DOI: 10.1371/journal.pone.0044741. View

20.

Zhang H, Wang D, Adell G, Sun X . WRAP53 is an independent prognostic factor in rectal cancer- a study of Swedish clinical trial of preoperative radiotherapy in rectal cancer patients. BMC Cancer. 2012; 12:294. PMC: 3504514. DOI: 10.1186/1471-2407-12-294. View